AEM vs KGC

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

KGC presents a stable deterministic health profile with a Piotroski F-Score of 4/9 and a defensive Graham Number of $17.71, though it is currently trading at a premium to this defensive floor. However, the growth-based Intrinsic Value of $57.52 and explosive earnings growth (237.9% YoY) suggest the market is pricing in significant expansion. The company's financial health is exceptional, characterized by negligible debt (Debt/Equity 0.09) and high profitability (ROE 31.48%). Despite a bearish technical trend, the fundamental trajectory and consistent earnings beats support a strong bullish outlook.